Connecting to SEC EDGAR… PricingSign in
← All filings
Immunocore Holdings plcIMCR · Nov 6, 9:00 AM ET

Immunocore reports Q3 2026 KIMMTRAK revenue of $102.2 million

Immunocore reported third-quarter 2026 KIMMTRAK net revenue of $102.2 million, a net loss of $14.2 million, and cash and marketable securities of $901 million as of September 30, 2026.

AI-generated summary, checked against the filing. Can contain errors: read the original filing ↗. Not investment advice.